ATRIPLA, BIKTARVY, GENVOYA, ODEFSEY, SYMFI. LILETTA FOR YOUR INFORMATION: Generics should be considered the first line of prescribing.
Individual is not a candidate (for example, drug-drug interactions, drug-disease interactions, Symfi tablets [prescribing information]. Morgantown, WV:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SYMFI safely and effectively. See full prescribing information for SYMFI. SYMFI (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2024 WARNING: POST TREATMENT ACUTE EXACERBATIONS OF
Symfi/ Symfi Lo. TDF 3TC EFV. X. CYP3A4 inducer substrate Tivicay (dolutegravir) prescribing information. Research Triangle Park, NC
ADULT DOSING One tablet of either Symfi or Symfi Lo once a day. Each tablet of Symfi contains 600mg efavirenz 300mg tenofovir disoproxil fumarate 300mg
Symfi; Symfi Lo. Warning. Hepatitis B has gotten worse when this and/or medication information. It is not meant to be comprehensive
SYMFI prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and SYMFIside effects.
Symfi/Symfi Lo. Topicort Spray; Verdeso. Desonide; desoximtasone. Fenoprofen AHFS Drug Information. Available at:
safely and effectively. See full prescribing information for SYMFI. SYMFI (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2024 WARNING: POST TREATMENT ACUTE EXACERBAT IONS OF HEPATITIS B. See full prescribing information for complete boxed warning.
Comments